FDA eases regulations on biosimilars to save billions on medications
Rising Costs in Prescription Drugs and the Role of Biosimilars The most rapidly growing area of health care spending is on prescription medications. At the forefront are biologics, which can cost up to $200,000 annually. There are “generic” alternatives known as biosimilars that have the potential to save Americans billions, yet their adoption is stymied […]